FOLH1 and neoplasm: The therapeutic efficacy of [177Lu]Lu-Ibu-DAB-PSMA in tumor-bearing nude mice was compared to the effect of [177Lu]Lu-PSMA-617, applied at the same activity levels and also set into relation with the therapy data obtained for the previously developed [177Lu]Lu-PSMA-ALB-56 [16].